Saroja Pharma IPO Details ( Saroja Pharma Industries India Limited IPO Review )
(31 Aug 2023 – 5 Sep 2023)
Founded in 2019, Saroja Pharma Industries India Limited is actively involved in the trade, export, and supply of Specialty Chemicals and Active Pharmaceutical Ingredients (APIs).
The company operates within three distinct product categories:
- Chemicals
- Pharmaceutical Intermediaries
- Veterinary Pharmaceutical APIs
Saroja Pharma Industries provides a range of products, including Liquid Bromine utilized as an agro-intermediate, Ethyl Acetate serving as an API solvent, as well as various pharmaceutical compounds for both human and veterinary medications, some of which also function as API solvents.
APIs, recognized as bulk drugs or bulk actives, serve as the core components in the production of finished dosage forms like capsules, tablets, liquids, and other dosage forms, often combined with other APIs or inactive ingredients.
The company primarily exports its products to countries such as Pakistan, Egypt, Russia, Jordan, Hong Kong, and Singapore.
Saroja Pharma Industries India Limited Company Product
- Liquid Bromine
- N-[(4S,6S)-6-Methyl-7,7-dioxido-2-sulfamoyl-5, 6-dihydro-4Hthieno[2,3-b]thiopyran-4yl) acetamide
- Ethyl Acetate
- Thionyl Chloride
- Para Nitro Phenol
- Oxyclozanide BP Vet
- Benzyl Chloride
- Bromhexine HCL BP Grade
- Triclabendazole
- Fenbendazole BP Vet
- Nitroxynil BP Vet
- Oxfendazole BP Vet
- Albendazole USP
- Rafoxanide BP Vet
- Febantel EP
Saroja Pharma Industries India Limited IPO Competitive Strength
- A seasoned team of promoters and management professionals
- A scalable business model
- A diverse and extensive product portfolio
- A broad spectrum of business operations contributing to a diversified revenue base
Saroja Pharma IPO Financials Performance ( Results )
Saroja Pharma Industries India Limited Financial Information (Restated Standalone)
All Amount in ₹ Lakhs
| Period Ended | Total Assets | Total Revenue | PAT | EPS (₹) | Net Worth | Reserves | Borrowing |
| 31-Mar-21 | 822.39 | 3,674.67 | 73.13 | 2.69 | 93.59 | 92.59 | 301.77 |
| 31-Mar-22 | 1,551.19 | 5,595.67 | 114.01 | 3.96 | 402.60 | 380.02 | 613.88 |
| 31-Mar-23 | 2,133.99 | 5,035.09 | 106.06 | 3.61 | 508.66 | 215.09 | 1,018.86 |
Objective of IPO Issue
- To Set-up a Manufacturing Unit
- To Repay the Unsecured Loans
- Public Issue Expenses
Saroja Pharma IPO Basic Details
| IPO Date | Aug 31, 2023 to Sep 5, 2023 |
| Listing Date | Wednesday, September 13, 2023 |
| Face Value | ₹10 per share |
| Price | ₹84 per share |
| Lot Size | 1600 Shares |
| Issue Size | 1,084,800 shares of ₹10 (aggregating up to ₹9.11 Cr) |
| Fresh Issue | 1,084,800 shares of ₹10 (aggregating up to ₹9.11 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 2,935,686 |
| Share holding post issue | 4,020,486 |
| Company Promoters | Mr. Biju Gopinathan Nair And Mr. Manish Dasharath Kamble |
Saroja Pharma IPO Reservation
| Market Maker Shares Offered | 5.01% of the Net Issue |
| Other Shares Offered | 47.49% of the Net Issue |
| Retail Shares Offered | 47.49% of the Net Issue |
| Total Shares Offered | 100.00% of the Net Issue |
Saroja Pharma IPO Timetable
Saroja Pharma IPO will open on August 31, 2023 and close on September 5, 2023. You can join Saroja Pharma IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.
| Event | Date |
| Opening Date | 31 August 2023 (Thursday) |
| Closing Date | 5 September 2023 (Tuesday) |
| Basis of Allotment | 8 September 2023 (Friday) |
| Initiation of Refunds | 11 September 2023 (Monday) |
| Credit of Shares to Demat | 12 September 2023 (Tuesday) |
| Listing Date | 13 September 2023 (Wednesday) |
| Deadline for UPI mandate confirmation | 5 PM on 5 September 2023 |
Saroja Pharma IPO Lot Size
For retail investors in Saroja Pharma IPO, 1600 shares will come in 1 lot or the minimum investment will be ₹134,400. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹134,400.
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 1600 | ₹134,400 |
| Retail (Max) | 1 | 1600 | ₹134,400 |
| S-HNI (Min) | 2 | 3200 | ₹268,800 |
Saroja Pharma IPO Promoter Holding
The company’s promoters include Mr. Biju Gopinathan Nair And Mr. Manish Dasharath Kamble.
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 73.02% |
Saroja Pharma Industries India Ltd IPO Key Performance Indicator ( Valuation )
In the table given below, all the figures have been told according to the latest financial year.
| KPI | Values |
| Market Cap (₹ Cr.) | Coming Soon |
| Earning Per Share (EPS) | ₹3.61 per Equity Share |
| Net Asset Value (NAV) | ₹17.33 per Equity Share |
| P/E Ratio (P/E) (x) | 23.27 |
| Return on Net Worth (RoNW) (%) | 20.85 |
| Return on equity (ROE) (%) | Coming Soon |
| Return on Capital Employed (ROCE) (%) | Coming Soon |
| Debt/Equity Ratio | 2.00 |
Saroja Pharma Industries India Ltd Peer Comparison
| Company Name | Consolidated/ Standalone | Face Value | EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) |
| Saroja Pharma Industries India Limited | Standalone | 10 | 3.61 | 23.27 | 20.85 | 17.33 |
| Peer Group | ||||||
| NGL Fine Chem Limited | Standalone | 5 | 84.57 | 23.15 | 25.29 | 334.35 |
| Sequent Scientific Limited | Standalone | 2 | 0.60 | 223.00 | 1.42 | 41.92 |
Saroja Pharma IPO GMP Live Update, Kostak Rate day by day
| Date | GMP | Kostak | Subject to |
| 6 September 2023 | ₹0 | – | – |
| 5 September 2023 | ₹0 | – | – |
| 4 September 2023 | ₹0 | – | – |
| 3 September 2023 | ₹0 | – | – |
| 2 September 2023 | ₹0 | – | – |
| 1 September 2023 | ₹0 | – | – |
| 31 August 2023 | ₹0 | – | – |
Saroja Pharma IPO Detail Video:
Saroja Pharma IPO Subscription Status (Bidding Detail)
The Saroja Pharma IPO on September 5, 2023 at 7:30:00 PM was subscribed 8.88 times, with the retail category being subscribed 14.83 times, other category being subscribed 2.90 times.
| Category | Subscription |
| Other | 2.90x |
| Retail | 14.83x |
| Total | 8.88x |
Saroja Pharma IPO Prospectus
| Saroja Pharma IPO DRHP | Download |
| Saroja Pharma IPO RHP | Download |
| Saroja Pharma IPO Anchor Investors Details PDF | Download |
Saroja Pharma IPO Rating
| Our Rating | 1.5/5.0 |
Saroja Pharma Company Contact Information
Saroja Pharma Industries India Limited
Registered office: 305, Kailash Tower, Shiv Shristi Complex,
Goregaon Link Road, Mulund West, Mumbai (MH) – 400080
Website: www.sarojapharma.com
Corporate Office: Shop No. 209, 2nd Floor, Ecstacy, City of Joy,
Jata Shankar Dosa Marg, Mulund West Mumbai (MH) – 400080
E-Mail: info@sarojapharma.com
Telephone No: +91 (022) 2081 0011
Company Secretary and Compliance Officer: Mrs. Nikita Kumar
Promoters Of The Company: Mr. Biju Gopinathan Nair And
Mr. Manish Dasharath Kamble
Saroja Pharma IPO Registrar
Kfin Technologies Limited
SEBI Registration Number: INR000000221
Address: Office: Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District,
Nanakramguda, Serilingampally, Hyderabad – 500 032, Telangana
Tel. Number: +91 40 6716 2222
Toll Free No.: 1800 309 4001
Email Id: spiil.ipo@kfintech.com
Investors Grievance Id: einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: Mr. M Murali Krishna
Saroja Pharma IPO Lead Manager
Swastika Investmart Limited
SEBI Registration Number: INM000012102
Merchant Banking Division Address: Flat No18 Floor 2 North Wing Madhaveshwar
Coop Hsg Society Ltd Madhav Nagar, 11/12 S V Road Andheri W Mumbai Mumbai City –
400058 (Maharashtra)
Telephone Number: +91-22-26254568-69
Email Id: merchantbanking@swastika.co.in
Investors Grievance Id: mb.investorgreivance@swastika.co.in
Website: www.swastika.co.in
Contact Person: Mr. Mohit R. Goyal
CIN: L65910MH1992PLC067052
Saroja Pharma IPO FAQs
What is the lot size of Saroja Pharma IPO?
The total size of Saroja Pharma IPO is ₹9.11 crores and this is a complete fresh Issue.
When will Saroja Pharma IPO start?
Saroja Pharma IPO will open from 31 August 2023 and IPO will close on 5 September 2023.
What is the open date of Saroja Pharma IPO?
Saroja Pharma IPO will open date from 31 August 2023.
What is the last date ( close date ) of Saroja Pharma IPO?
Saroja Pharma IPO will close from 5 September 2023.
What is the price band of Saroja Pharma IPO?
Saroja Pharma IPO price band is ₹84.
What is the minimum amount required to apply for Saroja Pharma IPO?
The minimum investment for retailers to apply for Saroja Pharma IPO is ₹134,400 and the maximum investment is ₹134,400.
What is going on gray market premium of Saroja Pharma IPO?
View gray market premium of Saroja Pharma IPO by Clicking Here
How much is the GMP of Saroja Pharma IPO?
Watch Saroja Pharma IPO GMP Today: Click Here
What is the allotment date of Saroja Pharma IPO?
The allotment date of Saroja Pharma IPO is 8 September 2023.
How to check allotment status in Saroja Pharma IPO?
To check the allotment status of Saroja Pharma IPO, first of all go to the registrar website by clicking here, select your bad Saroja Pharma IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )
What is the listing date of Saroja Pharma IPO?
The listing date of Saroja Pharma IPO is 13 September 2023.
How much will be the listing gain in Saroja Pharma IPO?
View listing gain of Saroja Pharma IPO by Clicking Here
How much time Saroja Pharma IPO is subscribed?
Total 8.88 times subscribed in Saroja Pharma IPO out of which 14.83 times subscription was done in retail quota, 2.90 times subscription in other quota.
How to apply for Saroja Pharma IPO from Upstox?
Click Here to see how to apply for Saroja Pharma IPO from Upstox. (step by step)
How to apply for Saroja Pharma IPO from Zerodha?
Click Here to see how to apply for Saroja Pharma IPO from Zerodha. (step by step)
How to apply for Saroja Pharma IPO from Angle One?
Click Here to see how to apply for Saroja Pharma IPO from Angle One. (step by step)
